OPIANT PHARMACEUTICALS INC (OPNT) Stock Analyst Ratings
USA - NASDAQ:OPNT - US6837501039 - Common Stock
20.65 USD
-0.12 (-0.58%)
20.75 USD
+0.1 (+0.48%)
ChartMill assigns a Buy % Consensus number of 46% to OPNT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.42. This target is 3.73% above the current price.
OPNT was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about OPNT.
In the previous month the buy percentage consensus was at a similar level.
OPNT was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-12-09 | Oppenheimer | Initiate | Outperform |
OPIANT PHARMACEUTICALS INC / OPNT FAQ
What is the price target for OPNT stock?
7 analysts have analysed OPNT and the average price target is 21.42 USD. This implies a price increase of 3.73% is expected in the next year compared to the current price of 20.65.
What is the consensus rating for OPNT stock?
The consensus rating for OPIANT PHARMACEUTICALS INC (OPNT) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
What is the number of analysts for OPNT stock?
The number of analysts covering OPIANT PHARMACEUTICALS INC (OPNT) is 7.